# Seqstant

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/seqstant

- Industry: Healthcare IT
- Headquarters: Teltow, Germany
- Website: www.seqstant.com
- Total disclosed funding: $1.9M
- Latest round: Seed (Sep 28, 2023)
- Investors on record: 4

## About

Based in Teltow, Germany, and founded by Henri Knobloch (CEO) and Tobias Loka (CSO), Seqstant GmbH operates as a developer of software for the analysis of pathogens and metagenomic diagnostics solutions. In November 2023, Seqstant GmbH raised EUR 1.8 million in seed funding led by new investor Brandenburg Kapital, with participation from other new investors SB21, Impact Investment Group, VLC Venture League, and HPI Seed Fund.

LiveGene, the primary offering of the company, utilizes a one-click method to completely automate the analysis of pathogens through sequencing, simplifying the entire procedure from the initiation of the device to the generation of the final report. The company helps improve the speed and precision of diagnoses within diagnostic laboratories for sensitive, specific, and user-friendly real-time genetic diagnostics.

The company intends to use the November 2023 funding to support the expansion of its manpower and commercialize its LiveGene product.

## Funding rounds

- Seed, Sep 28, 2023, $1.9M — Brandenburg Kapital, Mercutio GmbH, VLC Venture League, HPI Ventures

## Investors

- Brandenburg Kapital (https://capitalatlas.ai/funds/brandenburg-kapital) — Seed
- Mercutio GmbH — Seed
- VLC Venture League (https://capitalatlas.ai/funds/vlc-venture-league) — Seed
- HPI Ventures (https://capitalatlas.ai/funds/hpi-ventures) — Seed